
A type of drug that specifically targets BRCA breast cancers and has relatively few side effects may also benefit some people who don’t have BRCA mutations
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lU0ATQ
via
IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου